Silence Therapeutics in second deal with AstraZeneca

Tuesday 25 March 2008

Silence Therapeutics Plc has concluded a second collaboration with AstraZeneca in the field of RNA interference, a relatively new technology which is being investigated for the treatment of a number of major diseases.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

United Kingdom